GW Appoints Senior Industry Executive to President, North America and Relocates CEO to the U.S. U.S. Operations to be Located in Southern California LONDON, May 19, 2015 (GLOBE NEWSWIRE via COMTEX) — GW Pharmaceuticals plc (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary […]

Yardley, PA—May 19, 2015—Publicis Touchpoint Solutions, Inc —a leading provider of customized, omnichannel healthcare sales, service, and clinical teams—announced today that President and CEO Michelle Keefe has been named a PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) representing the most influential people in the healthcare industry today. PM360, a leading health-marketing industry […]

PARSIPPANY, NJ–(Marketwired – May 19, 2015) – Ogilvy CommonHealth Worldwide (www.ochww.com), the health behavior change specialists of Ogilvy & Mather (www.ogilvy.com), and a WPP company (NASDAQ: WPPGY) (www.wpp.com), today announced that Matt Giegerich, chairman & CEO of the network, has been named a “Transformational Leader” by leading health-marketing industry trade magazine PM360 for its inaugural […]

PARSIPPANY, NJ–(Marketwired – May 14, 2015) – Ogilvy CommonHealth Worldwide (www.ochww.com), the health behavior change experts of Ogilvy & Mather (www.ogilvy.com), and a WPP company (NASDAQ: WPPGY) (www.wpp.com), today announced Jill Lesiak, vice president, creative director at the network’s Parsippany-based agency, Ogilvy CommonHealth, was named an industry Rising Star by the Healthcare Businesswomen’s Association (HBA) […]

BOSTON, May 13, 2015 /PRNewswire/ — Beacon Health Options (Beacon), the nation’s premier behavioral health management company, announced today that Jay Curley has joined the company as Executive Vice President, Corporate Affairs and Chief of Staff to Chief Executive Officer Tim Murphy. In his new role, Mr. Curley will develop and oversee Beacon’s corporate affairs […]

— Appointment Reflects Company’s Expanded Clinical and Market Driven Focus —   For Immediate Release   Rockville, MD, May 7, 2015 – Synthetic Biologics, Inc. (NYSE MKT: SYN), a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, announced Maureen Early joined the team in the newly created position of Vice […]

— Executive Brings Significant Biotech Industry Leadership Experience to Team as Company Enters Next Phase of Development — For Immediate Release Rockville, MD, May 4, 2015 – Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of pathogen-specific therapeutics focused on protecting the microbiome, as well as treating other diseases, announced Steven A. Shallcross has been […]

GlaxoSmithKline (GSK) is under scrutiny Tuesday, after more analysts have called for its longstanding chief executive, Sir Andrew Witty, to either step up his performance or resign within the next year, as the company prepares to receive its new chairman later this week. “Mr. Witty is running out of time,” said Stephen Bailey, a fund […]

PLEASANTON, Calif., May 1, 2015 /PRNewswire/ — Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that Marta Antonucci has joined Thoratec in the newly created role of President, International. This new Europe-based position is responsible for all Thoratec commercial operations outside of North […]

DUBLIN, IRELAND–(Marketwired – May 1, 2015) – Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, today named John B. Thomas executive vice president, strategy and investor relations, reporting directly to Timothy P. Walbert, chairman, president and […]